Výsledky vyhľadávania

Nájdených záznamov: 16  
Váš dotaz: Kód záznamu = ("r028170" ALEBO "r028172" ALEBO "r028166" ALEBO "r028161" ALEBO "r028168" ALEBO "r028173" ALEBO "r028175" ALEBO "r028171" ALEBO "r028164" ALEBO "r028113" ALEBO "r028114" ALEBO "r028159" ALEBO "r028110" ALEBO "r028163" ALEBO "r028178" ALEBO "r028177")
  1. SYSr028170
    LBL
      
    ^^^^^naa^^22^^^^^^^^450^
    005
      
    20130617160137.7
    100
      
    $a 20040802a2004 m y0sloc0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Adrenal myelolipoma. 6 cases and review of the literature $f H. Wagnerova ... [et al.]
    215
      
    $c Obr., tab.
    320
      
    $a Res. angl.
    320
      
    $a Bibliogr. odkazy
    463
    -1
    $1 001 sllk_un_cat*sg000148_2004_004_004 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 51, no. 4 (2004), p. 300-305 $1 210 $a Bratislava $c Veda
    541
    1-
    $a Adrenálny myelolipóm. 6 prípadov a súborný referát
    606
    1-
    $a myelolipóm $x klasifikácia $x diagnostika $2 mesh $3 sllk_un_auth*d018209 $9 .
    606
    1-
    $a nádory kôry nadobličiek $x klasifikácia $x diagnostika $x terapia $2 mesh $3 sllk_un_auth*d000306 $9 .
    606
    1-
    $a hyperaldosteronizmus $x diagnostika $x patofyziológia $2 mesh $3 sllk_un_auth*d006929 $9 .
    606
    2-
    $a CT röntgenová $x metódy $2 mesh $3 sllk_un_auth*d014057 $9 .
    606
    2-
    $3 sllk_un_auth*d001344 $a pitva $9 . $2 mesh
    606
    2-
    $a prevalencia $2 mesh $3 sllk_un_auth*d015995 $9 .
    675
      
    $a 616.453-006-073.756.8 $v 2. $z slo
    701
    -1
    $3 sllk_un_auth*p0052941 $a Wagnerová $b Hedviga $4 070
    701
    -1
    $a Lazúrová $b Ivica $3 sllk_un_auth*p0028548 $4 070 $p I. interná klinika LF UPJŠ a FN LP, Košice
    701
    -1
    $a Bober $b Juraj $3 sllk_un_auth*p0025518 $4 070 $p I. chirurgická klinika LF UPJŠ a FNsP, Košice
    701
    -1
    $a Sokol $b L. $3 sllk_un_auth*p0055405 $4 070 $p Patologický ústav LF UPJŠ, Košice
    701
    -1
    $3 sllk_un_auth*p0061549 $a Zachar $b Marcel $p Department of radiology, University hospital, Košice $4 070
    801
    -0
    $a SK $b BA006 $c 20040802 $g AACR2
  2. SYSr028172
    LBL
      
    ^^^^^naa^^22^^^^^^^^450^
    005
      
    20130617160145.7
    100
      
    $a 20040802a2004 m y0sloc0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Advanced tracheal carcinoma - a therapeutic significance of HDR brachytherapy in palliative treatment $f J. Skowronek ... [et al.]
    215
      
    $c Grafy, tab.
    320
      
    $a Res. angl.
    320
      
    $a Bibliogr. odkazy
    463
    -1
    $1 001 sllk_un_cat*sg000148_2004_004_004 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 51, no. 4 (2004), p. 313-318 $1 210 $a Bratislava $c Veda
    541
    1-
    $a Pokročilý tracheály karcinóm - terapeutická významnosť HDR brachyterapie pri paliatívnej liečbe
    606
    1-
    $a nádory trachey $x komplikácie $x diagnostika $x terapia $2 mesh $3 sllk_un_auth*d014134 $9 .
    606
    1-
    $a brachyterapia $x klasifikácia $x metódy $2 mesh $3 sllk_un_auth*d001918 $9 .
    606
    1-
    $a starostlivosť paliatívna $x klasifikácia $x metódy $2 mesh $3 sllk_un_auth*d010166 $9 .
    606
    2-
    $3 sllk_un_auth*d015999 $a analýza multivariačná $9 . $2 mesh
    606
    2-
    $a prežívanie $2 mesh $3 sllk_un_auth*d013534 $9 .
    606
    2-
    $a výkony chirurgické operačné $2 mesh $3 sllk_un_auth*d013514 $9 .
    675
      
    $a 616.23-006.6-07-08 $v 2. $z slo
    701
    -1
    $a Skowronek $b J. $3 sllk_un_auth*p0066013 $4 070 $p Department of brachytherapy, Greatpoland cancer center, Poznan, Poland
    701
    -1
    $a Piotrowski $b T. $3 sllk_un_auth*p0066014 $4 070 $p Department of physics, Greatpoland cancer center, Poznan, Poland
    701
    -1
    $a Mlynarczyk $b W. $3 sllk_un_auth*p0037016 $4 070 $p Pneumology clinic, University of medical sciences, Poznan, Poland
    701
    -1
    $a Ramlau $b R. $3 sllk_un_auth*p0033677 $4 070 $p Pneumology department, Lung hospital, Poznan, Poland
    801
    -0
    $a SK $b BA006 $c 20040802 $g AACR2
  3. SYSr028166
    LBL
      
    ^^^^^naa^^22^^^^^^^^450^
    005
      
    20130617160347.9
    100
      
    $a 20040802a2004 m y0sloc0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Are stromal fibroblasts from cervical tumors suitable to predict normal tissue radiation reaction? $f A. Gasinska ... [et al.]
    215
      
    $c Grafy, obr., tab.
    320
      
    $a Res. angl.
    320
      
    $a Bibliogr. odkazy
    463
    -1
    $1 001 sllk_un_cat*sg000148_2004_004_004 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 51, no. 4 (2004), p. 285-292 $1 210 $a Bratislava $c Veda
    541
    1-
    $a Sú fibroblasty strómové z cervikálnych tumorov vhodné predpovedať normálnu reakciu tkaniva na radiáciu?
    606
    1-
    $3 sllk_un_auth*d017154 $a bunky stromálne $x patológia $x cytológia $9 . $2 mesh
    606
    1-
    $a fibroblasty $x klasifikácia $x cytológia $2 mesh $3 sllk_un_auth*d005347 $9 .
    606
    1-
    $a nádory krčka maternice $x diagnostika $x terapia $2 mesh $3 sllk_un_auth*d002583 $9 .
    606
    2-
    $a apoptóza $x genetika $2 mesh $3 sllk_un_auth*d017209 $9 .
    606
    2-
    $a reakcia na dávku žiarenia $2 mesh $3 sllk_un_auth*d004307 $9 .
    606
    2-
    $a estrogény $2 mesh $3 sllk_un_auth*d004967 $9 .
    606
    2-
    $a faktory vekové $2 mesh $3 sllk_un_auth*d000367 $9 .
    675
      
    $a 618.146-006.6:615.849.2 $v 2. $z slo
    701
    -1
    $a Gasinska $b A. $3 sllk_un_auth*p0069287 $4 070 $p Laboratory of radiation biology, Department of radiation therapy, Centre of oncology, Krakow and Department of medical radiation physics, Karolinska institutet, Stockholm, Sweden
    701
    -1
    $a Adamczyk $b A. $3 sllk_un_auth*p0037007 $4 070 $p Laboratory of radiation biology, Department of radiation therapy, Centre of oncology, Krakow
    701
    -1
    $a Kojs $b Z. $3 sllk_un_auth*p0069291 $4 070 $p Department of gynecological oncology, Centre of oncology, Krakow, Poland
    701
    -1
    $a Szumiel $b I. $3 sllk_un_auth*p0037008 $4 070 $p Department of radiobiology and health protection, Institute of nuclear chemistry and technology, Warsaw, Poland
    801
    -0
    $a SK $b BA006 $c 20040802 $g AACR2
  4. SYSr028161
    LBL
      
    ^^^^^naa^^22^^^^^^^^450
    005
      
    20130617160643.3
    100
      
    $a 20040802a2004 m y0sloc0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Bactericidal capacity of platelets in gastric cancer patients $f Z. Kamocki ... [et al.]
    215
      
    $c Tab.
    320
      
    $a Res. angl.
    320
      
    $a Bibliogr. odkazy
    463
    -1
    $1 001 sllk_un_cat*sg000148_2004_004_004 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 51, no. 4 (2004), p. 265-268 $1 210 $a Bratislava $c Veda
    541
    1-
    $a Baktericidná kapacita doštičiek u pacientov s nádorom žalúdka
    606
    1-
    $a nádory žalúdka $x diagnostika $x farmakoterapia $2 mesh $3 sllk_un_auth*d013274 $9 .
    606
    1-
    $a aktivita krvi, baktericídna $x imunológia $2 mesh $3 sllk_un_auth*d001770 $9 .
    606
    1-
    $a aktivácia trombocytov $x imunológia $2 mesh $3 sllk_un_auth*d015539 $9 .
    606
    2-
    $a výkony chirurgické na tráviacom systéme $x metódy $2 mesh $3 sllk_un_auth*d013505 $9 .
    606
    2-
    $a faktory rastové endotelové $x analýza $x biosyntéza $x použitie diagnostické $2 mesh $3 sllk_un_auth*d016228 $9 .
    606
    2-
    $a metastázy nádorové $x diagnostika $x patofyziológia $2 mesh $3 sllk_un_auth*d009362 $9 .
    675
      
    $a 616.33-006:616.155.2 $v 2. $z slo
    701
    -1
    $a Kamocki $b Z. $3 sllk_un_auth*p0036996 $4 070 $p II Department of general and gastroenterological surgery, Medical university of Bialystok, Poland
    701
    -1
    $a Matowicka-Karna $b J. $3 sllk_un_auth*p0036997 $4 070 $p Department of clinical laboratory diagnostics, Medical university of Bialystok, Poland
    701
    -1
    $a Piotrowski $b Z. $3 sllk_un_auth*p0036999 $4 070 $p II Department of general and gastroenterological surgery, Medical university of Bialystok, Poland
    701
    -1
    $a Kemona $b H. $3 sllk_un_auth*p0067685 $4 070 $p Department of clinical laboratory diagnostics, Medical university of Bialystok, Poland
    801
    -0
    $a SK $b BA006 $c 20040802 $g AACR2
  5. SYSr028168
    LBL
      
    ^^^^^naa^^22^^^^^^^^450^
    005
      
    20130617160942.6
    100
      
    $a 20040802a2004 m y0sloc0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Correlation of vascular endothelial growth factor (VEGF) and CEA with clinicopathological variables in colorectal cancer patients $f O. Celen ... [et al.]
    215
      
    $c Grafy, tab.
    320
      
    $a Res. angl.
    320
      
    $a Bibliogr. odkazy
    463
    -1
    $1 001 sllk_un_cat*sg000148_2004_004_004 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 51, no. 4 (2004), p. 293-299 $1 210 $a Bratislava $c Veda
    541
    1-
    $a Korelácia vaskulárneho rastového faktoru (VEGF) a CEA s klinicko-patologickými variáciami u pacientov s kolorektálnym karcinómom
    606
    1-
    $a nádory kolorektálne $x klasifikácia $x diagnostika $2 mesh $3 sllk_un_auth*d015179 $9 .
    606
    1-
    $3 sllk_un_auth*d040281 $a receptor 1 pre cievny endotelový rastový faktor $x analýza $9 . $2 mesh
    606
    1-
    $a neovaskularizácia patologická $x diagnostika $2 mesh $3 sllk_un_auth*d009389 $9 .
    606
    2-
    $3 sllk_un_auth*d002986 $a skúšanie klinické ako téma $x metódy $9 . $2 mesh
    606
    2-
    $3 sllk_un_auth*d013223 $a štatistika ako téma $x metódy $9 . $2 mesh
    606
    2-
    $3 sllk_un_auth*d000911 $a protilátky monoklonálne $x analýza $x použitie diagnostické $9 . $2 mesh
    675
      
    $a 616.34/.35-006 $v 2. $z slo
    701
    -1
    $a Celen $b O. $3 sllk_un_auth*p0037009 $4 070 $p Department of general surgery, Ankara oncology teaching and research hospital, Ankara, Turkey
    701
    -1
    $a Kahraman $b I. $3 sllk_un_auth*p0037010 $4 070 $p Department of general surgery, Ankara oncology teaching and research hospital, Ankara, Turkey
    701
    -1
    $a Yildirim $b E. $3 sllk_un_auth*p0037011 $4 070 $p Department of general surgery, Ankara oncology teaching and research hospital, Ankara, Turkey
    701
    -1
    $a Berberoglu $b U. $3 sllk_un_auth*p0037012 $4 070 $p Department of general surgery, Ankara oncology teaching and research hospital, Ankara, Turkey
    801
    -0
    $a SK $b BA006 $c 20040802 $g AACR2
  6. SYSr028173
    LBL
      
    ^^^^^naa^^22^^^^^^^^450^
    005
      
    20201022073441.4
    100
      
    $a 20040802a2004 m y0sloc0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Expression of p65 gene in experimental colon cancer under the influence of 5-fluorouracil given alone and in combination with hormonal modulation $f G. Melen-Mucha ... [et al.]
    215
      
    $c Obr., tab.
    320
      
    $a Res. angl.
    320
      
    $a Bibliogr. odkazy
    463
    -1
    $1 001 sllk_un_cat*sg000148_2004_004_004 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 51, no. 4 (2004), p. 319-324 $1 210 $a Bratislava $c Veda
    541
    1-
    $a Expresia génu p65 pri experimentálne vyvolanom nádore hrubého čreva, liečenom 5-fluorouracilom samotným alebo s hormonálnym ovplyvnením
    606
    1-
    $a nádory hrubého čreva $x klasifikácia $x diagnostika $2 mesh $3 sllk_un_auth*d003110 $9 .
    606
    1-
    $a expresia génu $x genetika $x účinky liekov $2 mesh $3 sllk_un_auth*d015870 $9 .
    606
    1-
    $a proteín onkogénový p65(gag-jun) $x analýza $x genetika $2 mesh $3 sllk_un_auth*d016759 $9 .
    606
    2-
    $a fluorouracil $x aplikácia a dávkovanie $x použitie terapeutické $2 mesh $3 sllk_un_auth*d005472 $9 .
    606
    2-
    $3 sllk_un_auth*d006730 $a hormóny, náhrady hormónov a antagonisty hormónov $x aplikácia a dávkovanie $9 . $2 mesh
    606
    2-
    $a chirurgia kolorektálna $2 mesh $3 sllk_un_auth*d003107 $9 .
    675
      
    $a 616.34-006.6-085 $v 2. $z slo
    701
    -1
    $3 sllk_un_auth*p0059449 $a Meleň-Mucha $b Gabriela $p Department of experimental endocrinology and hormone diagnostics, Medical university of Lodž, Poland $4 070
    701
    -1
    $a Balcerczak $b E. $3 sllk_un_auth*p0069126 $4 070 $p Department of pharmaceutical biochemistry, Molecular biology laboratory, Faculty of pharmacy, Medical university of Lodž, Poland
    701
    -1
    $3 sllk_un_auth*p0062214 $a Mucha $b Slavomír $p Department of clinical endocrinology, Institute of endocrinology, Medical university of Lodž, Poland $4 070
    701
    -1
    $a Panczyk $b M. $3 sllk_un_auth*p0037019 $4 070 $p Department of pharmaceutical biochemistry, Molecular biology laboratory, Faculty of pharmacy, Medical university of Lodž, Poland
    701
    -1
    $a Lipa $b S. $3 sllk_un_auth*p0037020 $4 070 $p Department of pharmaceutical biochemistry, Molecular biology laboratory, Faculty of pharmacy, Medical university of Lodž, Poland
    701
    -1
    $a Mirowski $b M. $3 sllk_un_auth*p0050629 $4 070 $p Department of pharmaceutical biochemistry, Molecular biology laboratory, Faculty of pharmacy, Medical university of Lodž, Poland
    801
    -0
    $a SK $b BA006 $c 20040802 $g AACR2
  7. SYSr028175
    LBL
      
    ^^^^^naa^^22^^^^^^^^450^
    005
      
    20130617160101.1
    100
      
    $a 20040802a2004 m y0sloc0103 ba
    101
    0-
    $a eng
    102
      
    $a SK
    200
    1-
    $a Expression profiling of human tumors $e diagnostic and research applications $f C. Altaner
    463
    -1
    $1 001 sllk_un_cat*sg000148_2004_004_004 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 51, no. 4 (2004), p. 325 $1 210 $a Bratislava $c Veda
    470
    -1
    $1 200 1 $a Expression profiling of human tumors $1 210 $a Totowa, New Jersey $c Humana Press $d 2003 $1 700 1 $a Ladanyi $b M. $1 701 1 $a Gerald $b W.L.
    541
    1-
    $a Profil expresie ľudských tumorov
    606
    1-
    $a onkológia lekárska $x klasifikácia $2 mesh $3 sllk_un_auth*d008495 $9 .
    606
    1-
    $a expresia génu $x genetika $x imunológia $2 mesh $3 sllk_un_auth*d015870 $9 .
    606
    1-
    $a diagnostika $2 mesh $3 sllk_un_auth*d003933 $9 .
    606
    2-
    $a oligonukleotidy $x analýza $2 mesh $3 sllk_un_auth*d009841 $9 .
    606
    2-
    $a genóm ľudský $2 mesh $3 sllk_un_auth*d015894 $9 .
    608
      
    $3 sllk_un_auth*d022921 $a recenzia knihy $2 mesh
    675
      
    $a 616-006.6-085:82-95 $v 2. $z slo
    700
    -1
    $a Altaner $b Čestmír $f 1933- $3 sllk_un_auth*p0020579 $4 675 $p Ústav experimentálnej onkológie SAV, Bratislava
    801
    -0
    $a SK $b BA006 $c 20040802 $g AACR2
  8. SYSr028171
    LBL
      
    ^^^^^naa^^22^^^^^^^^450^
    005
      
    20130617160915.5
    100
      
    $a 20040802a2004 m y0sloc0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Choroid plexus tumors: a review of 28-years experience $f P. Strojan ... [et al.]
    215
      
    $c Obr., tab.
    320
      
    $a Res. angl.
    320
      
    $a Bibliogr. odkazy
    463
    -1
    $1 001 sllk_un_cat*sg000148_2004_004_004 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 51, no. 4 (2004), p. 306-312 $1 210 $a Bratislava $c Veda
    541
    1-
    $a Nádory chorioidey: súborný referát pri 28-ročnej skúsenosti
    606
    1-
    $a plexus chorioideus, papilóm $x patológia $2 mesh $3 sllk_un_auth*d020288 $9 .
    606
    1-
    $a incidencia $2 mesh $3 sllk_un_auth*d015994 $9 .
    606
    1-
    $a histológia $x klasifikácia $2 mesh $3 sllk_un_auth*d006653 $9 .
    606
    2-
    $a faktory vekové $2 mesh $3 sllk_un_auth*d000367 $9 .
    606
    2-
    $a komory mozgové $x abnormality $x anatómia a histológia $2 mesh $3 sllk_un_auth*d002552 $9 .
    606
    2-
    $a farmakoterapia kombinovaná $2 mesh $3 sllk_un_auth*d004359 $9 .
    606
    2-
    $a rádioterapia adjuvantná $2 mesh $3 sllk_un_auth*d018714 $9 .
    675
      
    $a 616.8-006-07-085 $v 2. $z slo
    701
    -1
    $a Strojan $b P. $3 sllk_un_auth*p0058277 $4 070 $p Department of radiotherapy, Institute of oncology, Ljubljana, Slovenia
    701
    -1
    $3 sllk_un_auth*p0037014 $a Popovič $b Mikuláš $f 1941- $p Institute of pathology, Medical faculty University of Ljubljana, Slovenia $4 070
    701
    -1
    $a Šurlan $b K. $3 sllk_un_auth*p0037015 $4 070 $p Institute of radiology, University clinical center, Ljubljana, Slovenia
    701
    -1
    $a Jereb $b B. $3 sllk_un_auth*p0050898 $4 070 $p Department of radiotherapy, Institute of oncology, Ljubljana, Slovenia
    801
    -0
    $a SK $b BA006 $c 20040802 $g AACR2
  9. SYSr028164
    LBL
      
    ^^^^^naa^^22^^^^^^^^450^
    005
      
    20160311155045.7
    100
      
    $a 20040802a2004 m y0sloc0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer $f P. Plevová ... [et al.]
    215
      
    $c Tab.
    320
      
    $a Res. angl.
    320
      
    $a Bibliogr. odkazy
    463
    -1
    $1 001 sllk_un_cat*sg000148_2004_004_004 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 51, no. 4 (2004), p. 275-284 $1 210 $a Bratislava $c Veda
    541
    1-
    $a Imunohistochemická detekcia hMLH1 a hMSH2 proteínov pri vrodenom nepolypóznom a pri sporadickom nádore hrubého čreva
    606
    1-
    $a nádory kolorektálne bez polypózy, dedičné $x diagnostika $x terapia $2 mesh $3 sllk_un_auth*d003123 $9 .
    606
    1-
    $a nádory hrubého čreva $x diagnostika $x chirurgia $2 mesh $3 sllk_un_auth*d003110 $9 .
    606
    1-
    $a imunohistochémia $x metódy $2 mesh $3 sllk_un_auth*d007150 $9 .
    606
    2-
    $a analýza DNA, mutačná $x metódy $2 mesh $3 sllk_un_auth*d004252 $9 .
    606
    2-
    $3 sllk_un_auth*d005820 $a testovanie genetické $x klasifikácia $x metódy $9 . $2 mesh
    606
    2-
    $a repetície mikrosatelitné $x genetika $x imunológia $2 mesh $3 sllk_un_auth*d018895 $9 .
    675
      
    $a 616.34-006.6-089-07 $v 2. $z slo
    701
    -1
    $3 sllk_un_auth*p0037003 $a Plevová $b Pavlína $p Institute of pathology and laboratory of molecular pathology, Medical faculty of the Palacký university, Olomouc and Department of radiotherapy, Faculty hospital of Ostrava, Czech Republic $4 070
    701
    -1
    $a Křepelová $b Anna $3 sllk_un_auth*p0067863 $4 070 $p Ústav biologie a lékařské genetiky 2. LF UK a FN Motol, Praha
    701
    -1
    $3 sllk_un_auth*p0037004 $a Sekowská $b Martina $f 1975- $p Institute of biology and genetics, 1st Medical faculty of Charles university, Prague, Czech Republic $4 070
    701
    -1
    $3 sllk_un_auth*p0036560 $a Sedláková $b Eva $p Institute of pathology and laboratory of molecular pathology, Medical faculty of the Palacký university, Olomouc $4 070
    701
    -1
    $3 sllk_un_auth*p0066255 $a Čuřík $b Romuald $p Department of pathology, University hospital, Ostrava $4 070
    701
    -1
    $3 sllk_un_auth*p0025918 $a Foretová $b Lenka $f 1957- $p Masaryk memorial cancer institute, Brno $4 070
    701
    -1
    $a Navrátilová $b M. $3 sllk_un_auth*p0066145 $4 070 $p Masaryk memorial cancer institute, Brno
    701
    -1
    $a Novotný $b J. $3 sllk_un_auth*p0031792 $4 070 $p Department of oncology, 1st Medical faculty of Charles university and Teaching hospital, Prague, Czech Republic
    701
    -1
    $a Zapletalová $b Jana $3 sllk_un_auth*p0060835 $4 070 $p Ústav lékařské biofyziky, odd. biometrie, Univerzita Palackého, Olomouc
    701
    -1
    $a Palas $b J. $3 sllk_un_auth*p0037005 $4 070 $p Department of pathology, Silesian hospital, Opava, Czech Republic
    701
    -1
    $a Nieslanik $b J. $3 sllk_un_auth*p0037006 $4 070 $p Department of pathology, Municipal hospital of Ostrava
    701
    -1
    $a Horáček $b J. $3 sllk_un_auth*p0034400 $4 070 $p Laboratory of cytology, Ostrava
    701
    -1
    $3 sllk_un_auth*0017892 $a Dvořáčková $b Jana $f 1956- $p NZZ Cytologická a bioptická laboratoř, Ostrava $4 340
    701
    -1
    $3 sllk_un_auth*p0052332 $a Kolář $b Zdeněk $f 1953- $p Institute of pathology and laboratory of molecular pathology, Medical faculty of the Palacký university, Olomouc $4 070
    801
    -0
    $a SK $b BA006 $c 20040802 $g AACR2
  10. SYSr028113
    LBL
      
    ^^^^^naa^^22^^^^^^^^450
    005
      
    20130617160316.2
    100
      
    $a 20040729a2004 m y0sloc0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Increasing occurrence of urological cancers in Slovakia $f I. Pleško ... [et al.]
    215
      
    $c Grafy, tab.
    320
      
    $a Res. angl.
    320
      
    $a Bibliogr. odkazy
    463
    -1
    $1 001 sllk_un_cat*sg000148_2004_004_004 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 51, no. 4 (2004), p. 248-254 $1 210 $a Bratislava $c Veda
    541
    1-
    $a Zvýšený výskyt urologických nádorov na Slovensku
    606
    1-
    $a nádory urologické $x klasifikácia $x diagnostika $2 mesh $3 sllk_un_auth*d014571 $9 .
    606
    1-
    $a úmrtnosť $2 mesh $3 sllk_un_auth*d009026 $9 .
    606
    1-
    $a incidencia $2 mesh $3 sllk_un_auth*d015994 $9 .
    606
    2-
    $a nádory prostaty $x komplikácie $x diagnostika $2 mesh $3 sllk_un_auth*d011471 $9 .
    606
    2-
    $a nádory močového mechúra $x diagnostika $x terapia $2 mesh $3 sllk_un_auth*d001749 $9 .
    606
    2-
    $a nádory obličiek $x terapia $x diagnostika $2 mesh $3 sllk_un_auth*d007680 $9 .
    607
      
    $a Slovensko $2 mesh $3 sllk_un_auth*d018154
    675
      
    $a 616.61-006.6-07-08(437.6) $v 2. $z slo
    701
    -1
    $3 sllk_un_auth*p0002506 $a Pleško $b Ivan $f 1930-2016 $4 070
    701
    -1
    $3 sllk_un_auth*p0055875 $a Obšitníková $b Adriana $4 070
    701
    -1
    $3 sllk_un_auth*p0043447 $a Ondrušová $b Martina $p Oddelenie epidemiológie nádorov, Ústav experimentálnej onkológie SAV, Bratislava $4 070
    701
    -1
    $a Tomášek $b L. $3 sllk_un_auth*p0060733 $4 070
    701
    -1
    $a Stefanakova $b D. $3 sllk_un_auth*p0036967 $4 070
    701
    -1
    $3 sllk_un_auth*p0027802 $a Kubík $b Antonín $4 070
    801
    -0
    $a SK $b BA006 $c 20040729 $g AACR2

  Tieto stránky využívajú súbory cookies, ktoré uľahčujú ich prezeranie. Ďalšie informácie o tom ako používame cookies.